Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixivaptan in Euvolemic Hyponatremia (LIBRA)
NCT00660959Phase 3Completed
- Sponsor
- CardioKine
- Start
- Apr 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of lixivaptan in Euvolemic hyponatremia, sponsored by CardioKine. Started Apr 2008; status: completed.
02
Drugs
lixivaptan
03
Conditions
Euvolemic hyponatremia
Beyond the preview
Go deeper on NCT00660959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660959.